Feb. 16 at 2:27 PM
$CME CME Group price target raised to
$232 from
$229 at BofA
BofA raised the firm's price target on CME Group to
$232 from
$229 and keeps an Underperform rating on the shares. Following in-line results, the firm slightly increased its Q1, 2026, 2027 and 2028 non-GAAP EPS estimates to embed stronger commodities volume quarter-to-date, partially offset by a higher than expected expense outlook.